These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5127366)

  • 21. [Pharmacological study of prostate extracts. (IV). Prostatic acid phosphotases from several different species, and the effect of prostate extracts on these enzymes].
    Koda A; Hiramatsu M; Yoshida Y
    Nihon Yakurigaku Zasshi; 1974 Sep; 70(5):609-19. PubMed ID: 4141986
    [No Abstract]   [Full Text] [Related]  

  • 22. [Current assessment of radioimmunological determination (RIA) of prostate acid phosphatase in the diagnosis of prostatic cancer].
    Huber PR; Hagmaier V; Scholer A; Lyrer P; Christen P; Wolf T; Kanszo G; Hassel JP; Rutishauser G
    Helv Chir Acta; 1981 Aug; 48(3-4):445-52. PubMed ID: 7287483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Determination and establishment of normal limits of total and prostatic acid phosphatase activity].
    Kreutzmann H
    Z Urol Nephrol; 1970 Nov; 63(11):857-64. PubMed ID: 5511375
    [No Abstract]   [Full Text] [Related]  

  • 24. Characteristics of murine prostatic acid phosphatase: comparison with other tissues and species.
    Iype PT; Heidelberger C
    Arch Biochem Biophys; 1968 Nov; 128(2):434-41. PubMed ID: 5698031
    [No Abstract]   [Full Text] [Related]  

  • 25. Organ-specificity and sensitivity of serum enzyme tests in clinical diagnosis: current concepts.
    Fenuku RI
    Ghana Med J; 1973 Dec; 12(4):403-7. PubMed ID: 4808053
    [No Abstract]   [Full Text] [Related]  

  • 26. Radioimmunoassay for prostatic acid phosphatase helps discriminate patients with prostatic cancer.
    Blick KE; Dick TT; Webb TA
    Clin Chem; 1982 Dec; 28(12):2373-7. PubMed ID: 6183027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The possible sources of serum acid phosphatase in the dog following hepatic ischemia.
    Daniel AM; Blevings S; Beaudoin JG; MacLean LD
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):894-8. PubMed ID: 5023781
    [No Abstract]   [Full Text] [Related]  

  • 28. Radioimmunoassay of prostatic acid phosphatase: validation and clinical application.
    Franchimont P; Bouffioux C; Reuter A; Rigo-Betz C; Vrindts-Gevaert Y; Jaspar JM; Lecomte-Yerna MJ
    Int J Cancer; 1983 Feb; 31(2):149-55. PubMed ID: 6826245
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved determination of prostatic acid phosphatase (sodium thymolphthalein monophosphate substrate).
    Ewen LM; Spitzer RW
    Clin Chem; 1976 May; 22(5):627-32. PubMed ID: 1261011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum prostatic acid phosphatase].
    Chen M; Gai M; Fishelovitz J; Hegesh E
    Harefuah; 1983 May; 104(9):378-80. PubMed ID: 6674043
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the measurement of serum prostatic acid phosphatase with RIA-Quant PAP test kit (author's transl)].
    Kawamura J; Yoshida O; Kousaka T; Yoshii M; Morita R; Torizuka K
    Kaku Igaku; 1982 Mar; 19(2):313-22. PubMed ID: 7109329
    [No Abstract]   [Full Text] [Related]  

  • 32. Acid phosphatase measurement in the clinical laboratory.
    Bowers GN
    Ann N Y Acad Sci; 1982; 390():89-99. PubMed ID: 6953926
    [No Abstract]   [Full Text] [Related]  

  • 33. Plasma alkaline phosphatase isoenzymes in hepatobiliary disease.
    Afonija AO; Baron DN
    J Clin Pathol; 1974 Nov; 27(11):916-20. PubMed ID: 4443409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods.
    Romas NA; Veenema RJ; Hsu KC; Tomashefsky P; Lattimer JK; Tannenbaum M
    Trans Am Assoc Genitourin Surg; 1979; 71():26-30. PubMed ID: 545810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase.
    Lee CL; Killian CS; Murphy GP; Chu TM
    Clin Chim Acta; 1980 Feb; 101(2-3):209-16. PubMed ID: 7357745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heterogeneity of prostatic acid phosphatase.
    Smith JK; Whitby LG
    Biochim Biophys Acta; 1968 Mar; 151(3):607-18. PubMed ID: 5689552
    [No Abstract]   [Full Text] [Related]  

  • 37. Ratio of serum tartrate-inhibitable acid phosphatase to total serum protein in benign prostatic hypertrophy and prostatic carcinoma.
    Petrovich G; Ursich-Jankovich J; Prijovich Z
    Clin Chem; 1992 Feb; 38(2):276-7. PubMed ID: 1371723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Critical observations on the use of phenolphthalein monophosphate as a substrate for the determination of prostatic acid phosphatase (author's transl)].
    Gallati H
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):323-8. PubMed ID: 19554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of a new solid-phase direct immunoenzyme assay for prostatic acid phosphatase.
    Gericke K; Kohse KP; Pfleiderer G; Flüchter SH; Bichler KH
    Clin Chem; 1982 Apr; 28(4 Pt 1):596-602. PubMed ID: 7042116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fractionation and purification of prostatic acid phosphatase.
    Pais VM; Mangold AW; Mahoney SA
    Invest Urol; 1974 Jul; 12(1):13-6. PubMed ID: 4135033
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.